Log in

LON:SENS - Sensyne Health Share Price, Forecast & News

GBX 54
-0.50 (-0.92 %)
(As of 02/17/2020 07:02 AM ET)
Today's Range
Now: GBX 54
50-Day Range
MA: GBX 57.58
52-Week Range
Now: GBX 54
Volume3,703 shs
Average VolumeN/A
Market Capitalization£69.43 million
P/E RatioN/A
Dividend YieldN/A
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. Read More…

Industry, Sector and Symbol

Industry Health Information Services
SectorComputer and Technology
Phone44 3300 581845



Sales & Book Value

Annual Sales£489,000.00
Cash FlowGBX 29.08 per share
Book ValueGBX 43.40 per share



Market Cap£69.43 million
Next Earnings DateN/A

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Sensyne Health (LON:SENS) Frequently Asked Questions

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

What price target have analysts set for SENS?

3 analysts have issued 1 year target prices for Sensyne Health's shares. Their forecasts range from GBX 195 to GBX 262. On average, they expect Sensyne Health's stock price to reach GBX 239 in the next year. This suggests a possible upside of 342.6% from the stock's current price. View Analyst Price Targets for Sensyne Health.

What is the consensus analysts' recommendation for Sensyne Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensyne Health.

Has Sensyne Health been receiving favorable news coverage?

Headlines about SENS stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sensyne Health earned a news impact score of 1.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Sensyne Health.

Who are some of Sensyne Health's key competitors?

What other stocks do shareholders of Sensyne Health own?

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 54.

How big of a company is Sensyne Health?

Sensyne Health has a market capitalization of £69.43 million and generates £489,000.00 in revenue each year. Sensyne Health employs 70 workers across the globe.View Additional Information About Sensyne Health.

What is Sensyne Health's official website?

The official website for Sensyne Health is http://www.sensynehealth.com/.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.

MarketBeat Community Rating for Sensyne Health (LON SENS)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  71
MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel